Australians frequently travel to countries with a high incidence of tuberculosis (TB). What risk does TB pose to travellers and what can be done to mitigate this risk?
In the year ending June 2016, 9.7 million Australian residents left Australia visiting one or more countries for a short term period 1 
.
Of the 10 most common short term destinations, six were countries with TB incidence rates of >40 per 100 000, a threshold in common usage to define 'high incidence' (Table 1) 2 , contrasting sharply with the low TB incidence in Australia (5.3 per 100 000).
Three of these destinations, China, Indonesia and India account for 45% of the world's total number of notified TB cases. A significant burden of multi-drug resistant (MDR) TB is noted in India and China and to a lesser extent Indonesia ( Figure 1 ). While risks of TB to travellers have recently been reviewed comprehensively elsewhere 3 this short overview seeks to address key questions in understanding TB in the context of travel. 
Assessing the risk
The likelihood of acquiring TB is determined by the probability of encountering one or more infectious cases and the cumulative duration of exposure. Host factors increase the risk that asymptomatic infection, (latent TB (LTB)), will progress to active disease and how severe that disease may be. In addition disease is most likely to manifest in the 2-5 years following acquisition.
The risk of acquiring infection for travellers, as assessed by tests for LTB such as the tuberculin skin test (TST) and interferon gamma release assays (IGRA), broadly is proportionate to the TB incidence in country of destination and the duration of stay.
However this is not always the case and risk is substantially affected by variations in TB incidence in-country, living circumstances during the period of travel and activities pursued during travel.
Participation in healthcare in countries of high burden is particularly acknowledged as both a risk for contracting TB and for the TB strain to be drug resistant. 'Medical tourism', seeking elective surgery overseas, is commonly to countries of high TB burden and may present additional risks of nosocomial or community transmission of TB.
Travellers previously treated for TB remain at risk of a new infection
in communities with high rates of TB transmission.
Some of the most devastating manifestations of TB such as miliary TB and meningitis are more likely to occur in children under the age of five years and especially those less than age 2. Young children accompanying their migrant parents to countries of high TB burden to visit relatives and friends may be exposed to a significant risk of TB, especially if a household contact has untreated tuberculosis, regardless of the risk of TB as determined by overall country incidence. , a situation which is unsatisfactory and remains unresolved.
Getting there and getting about
In the absence of BCG vaccine, post travel testing for LTB is an alternative and also applicable to older children and adults where BCG is generally not recommended. Two to three months Cargo compartment Serial IGRA testing in HCWs who are initially IGRA negative is complicated by spontaneous conversions and reversions and some authorities advise against its use in this setting 13 .
Post travel assessment
It is important that active TB is considered diagnostically at the first In Focus
